Zoll Medical (NSDQ:Zoll) won Shonin approval from Japan’s Ministry of Health, Labour & Welfare for its X Series monitor/defibrillator system.
The company’s Japanese subsidiary, Asahi Kasei Zoll Medical, developed the product and is heading to market in Japan. The monitor/defibrillator is compact, at less than 12 lbs, and features Zoll’s See-Thru CPR and Real CPR Help, which are used to minimize pauses in CPR and provide real-time feedback.
The X Series allows emergency responders to assess a patient’s needs quickly and to wirelessly transmit critical information to a receiving hospital so clinicians are prepared when the ambulance arrives, Zoll said.
“We are very excited to begin commercialization of the X Series in Japan and to continue to offer innovative technologies and devices for acute critical care to this high-growth market," CEO Richard Packer said in prepared remarks. "The X Series not only helps rescuers save lives, but makes the lives of first responders a great deal easier by having so many life-saving capabilities in 1 unit."
The Chelmsford, Mass.-based company is currently in litigation with Philips (NYSE:PHG) over a patent infringement row. Phillips sued Zoll in 2010, alleging infringement of 15 AED patents. Zoll followed it up with a lawsuit over 5 AED patents.